Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
His current translational research efforts focus on developing a novel small molecule treatment of lung cancer (Stat-3 inhibitor oncrasin-72) and revealing the prognostic and therapeutic role of the biomarker PKR/eIF2 a
To make payment choices actionable, the next section outlines who qualifies for GLP-1 therapy and how TeleSlim assesses clinical eligibility before prescribing
Publications (56) Journal Impact Factor Most Recent Signal Transduct Target Ther Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS
Its lyophilized peptide powder format supports stable handling and storage under recommended conditions for controlled scientific protocols
Peng D, Hu T, Soutto M, Belkhiri A, Zaika A, El-Rifai W
US$ 28.73
US$ 23.28
US$ 24.32
US$ 28.68
